Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) is submitting a clinical trial application (CTA) for a Phase I combinatorial study that will document the...
PharmaAla to supply the MDMA. The post Revive, PharmaTher To Partner on MDMA Patch appeared first on Green Market Report.
The article FDA Grants Pharmather Orphan Drug Designation for KETARX (Ketamine) was originally published on Microdose. Pharmather continues to add to...
Potential for $60 million. The post Irwin Naturals Raises $40 Million For Clinic Expansion appeared first on Green Market Report.
Previous studies have suggested ketamine has the potential to promote synaptic repair in Rett syndrome. The post PharmaTher One Step Closer to Commercializing...
Final price per share still to be determined. The post Irwin Naturals Signs LOI to Acquire Braxia Scientific appeared first on Green Market Report.
Clearmind Medicine Inc. (NASDAQ: CMND | CSE: CMND | FSE: CWY), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics...
Traditional tactics aren't always the most effective ways to raise capital. The post Psychedelics Industry Goal: Find Capital ASAP appeared first on Green...
Source: Streetwise Reports 01/24/2023 Awakn Life Sciences announced further details regarding its August 2022 announcement that it had "signed...
Could synthetic psychedelics help pave the way? The post Operators Seek to Reduce Cost of Psychedelics appeared first on Green Market Report.